Eli Lilly Covid Antibody Trial Paused Due to Safety Concerns

(Bloomberg) -- Eli Lilly & Co. paused enrollment of participants in a clinical trial of its antibody treatment for Covid-19 due to a potential safety concern, pushing down the company’s shares.